# Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction

> **NCT03767036** · PHASE1 · COMPLETED · sponsor: **Grünenthal GmbH** · enrollment: 30 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Tramadol hydrochloride 25 mg capsule
- **DRUG:** Ketorolac Tromethamine 10 mg tablet

## Key facts

- **NCT ID:** NCT03767036
- **Lead sponsor:** Grünenthal GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-05
- **Primary completion:** 2017-06-28
- **Final completion:** 2017-06-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03767036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03767036, "Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03767036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*